Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Phoenix, Arizona 85006


Purpose:

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.


Study summary:

Patients will be randomized to receive either placebo (versa base gel) or morphine gel to wound. Patients receiving morphine gel will have a decrease in pain score and use less oral/intravenous pain medications.


Criteria:

Inclusion Criteria: - Signed and dated consent form & HIPAA - > 18 yo - Single stage 2-3 wound - No allergy to morphine - Alert and oriented (thinking ability clear and intact, physician approval) - English language proficiency Exclusion Criteria: - Allergy to morphine, codeine, or versa base, pts taking medications for acute condition, other than for the wound pain - Patients with neuropathies - Patients with respiratory conditions


NCT ID:

NCT00755989


Primary Contact:

Principal Investigator
Mary Whitmer, MSN,FNP, APRN BC-PCM
Banner Health

Mary Whitmer, FNP
Phone: 602-239-6078
Email: marywhitmer@bannerhealth.com


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85006
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.